FERMENTALG (EPA:FALG)

BRIEF

published on 07/31/2024 at 07:35, 3 months 23 days ago

Fermentalg: General meeting on September 17, 2024

General Assembly Increase In Capital FERMENTALG Industrial Partnership HuvePharma
BRIEF

published on 07/10/2024 at 18:05, 4 months 12 days ago

FERMENTALG: Information on voting rights and shares

Voting Rights Actions AMF Publication FERMENTALG
BRIEF

published on 07/04/2024 at 18:05, 4 months 18 days ago

Fermentalg records record turnover of €6.3 million in the first half of 2024

Partnership Turnover FERMENTALG HuvePharma Marine Biotechnology
PRESS RELEASE

published on 07/04/2024 at 18:00, 4 months 18 days ago

Thanks to sales of EUR6.3 million, Fermentalg closes a historic 1st half-year 2024, also marked by its strategic agreement with HuvePharma
Fermentalg reports strong sales growth in H1 2024, exceeding targets. Partners with HuvePharma for sustainable solutions. Annual sales target raised to €12M. Strategic alliance for a competitive, sustainable supply

Sustainable Solutions Sales Growth FERMENTALG HuvePharma H1 2024
BRIEF

published on 07/02/2024 at 18:35, 4 months 20 days ago

Half-yearly review of the liquidity contract between Fermentalg and Gilbert Dupont

Liquidity Contract Actions Gilbert Dupont Half-year Results FERMENTALG
BRIEF

published on 06/18/2024 at 07:35, 5 months 5 days ago

Success of Fermentalg's capital increase with support of €12.8 million

Euronext Growth Increase In Capital FERMENTALG Bpifrance HuvePharma
PRESS RELEASE

published on 06/18/2024 at 07:30, 5 months 5 days ago

Successful capital increase for a total amount of EUR12.8m, with the support of Fermentalg's industrial partner HuvePharma and Bpifrance, to create the European champion for microalgae fermentation solutions
Fermentalg successfully completes €12.8 million capital increase to support 2024-2026 strategic plan and strengthen its position as a leader in sustainable marine microalgae solutions

Sustainable Solutions Capital Increase FERMENTALG HuvePharma Marine Microalgae
BRIEF

published on 06/17/2024 at 17:40, 5 months 5 days ago

Fermentalg Launches €12 Million Capital Increase with HuvePharma's Support

Fundraising Capital Increase FERMENTALG Microalgae HuvePharma
PRESS RELEASE

published on 06/17/2024 at 17:35, 5 months 5 days ago

Launch of a capital increase open to institutional and retail investors for a total of approximately EUR12 million, with the support of HuvePharma, Fermentalg's industrial partner
Fermentalg announces a €12 million capital increase with support from HuvePharma to lead in microalgae fermentation solutions. Sales targets raised amidst strong growth momentum. Funds to achieve financial equilibrium by 2026

Capital Increase Sales Targets FERMENTALG HuvePharma Microalgae Fermentation Solutions
BRIEF

published on 06/04/2024 at 18:05, 5 months 18 days ago

Information on the number of shares and voting rights of Fermentalg

Voting Rights Actions AMF Financial Publication FERMENTALG

Published on 11/22/2024 at 23:55, 10 hours 43 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 8 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 33 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 11 hours 33 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 8 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 16 hours 23 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 16 hours 38 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 16 hours 44 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 42 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 38 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 20 hours 3 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News